NCT06953518View on ClinicalTrials.gov

An Open-Label Pilot Study of Qualia Senolytic Supplementation for the Attenuation of Systemic Inflammatory Cytokines

NANot yet recruitingINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

May 12, 2025

Primary Completion Date

May 18, 2025

Study Completion Date

May 18, 2025

Conditions

Inflammation

Interventions

DIETARY_SUPPLEMENT

Qualia Senolytic

Qualia Senolytic manufactured by Qualia Life Science

Trial Locations (1)

92011

Qualia Life Sciences, Carlsbad

All Listed Sponsors

lead

Qualia Life Sciences

INDUSTRY